AAAAAA

   
Results: 1-16 |
Results: 16
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies
Authors: Ruprecht, RM Hofmann-Lehmann, R Smith-Franklin, BA Rasmussen, RA Liska, V Vlasak, J Xu, W Baba, TW Chenine, AL Cavacini, LA Posner, MR Katinger, H Stiegler, G Bernacky, BJ Rizvi, TA Schmidt, R Hill, LR Keeling, ME Montefiori, DC McClure, HM
Citation: Rm. Ruprecht et al., Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies, TRANSF CL B, 8(4), 2001, pp. 350-358
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B
Authors: Xu, WD Smith-Franklin, BA Li, PL Wood, C He, J Du, QJ Bhat, GJ Kankasa, C Katinger, H Cavacini, LA Posner, MR Burton, DR Chou, TC Ruprecht, RM
Citation: Wd. Xu et al., Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B, J HUMAN VIR, 4(2), 2001, pp. 55-61
Docetaxel in squamous cell cancer of the head and neck
Authors: Posner, MR
Citation: Mr. Posner, Docetaxel in squamous cell cancer of the head and neck, ANTI-CANC D, 12, 2001, pp. S21-S24
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancerof the head and neck
Authors: Posner, MR Glisson, B Frenette, G Al-Sarraf, M Colevas, AD Norris, CM Seroskie, JD Shin, DM Olivares, R Garay, CA
Citation: Mr. Posner et al., Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancerof the head and neck, J CL ONCOL, 19(4), 2001, pp. 1096-1104
Passive immunization against oral AIDS virus transmission: An approach to prevent mother-to-infant HIV-1 transmission?
Authors: Hofmann-Lehmann, R Rasmussen, RA Vlasak, J Smith, BA Baba, TW Liska, V Montefiori, DC McClure, HM Anderson, DC Bernacky, BJ Rizvi, TA Schmidt, R Hill, LR Keeling, ME Katinger, H Stiegler, G Posner, MR Cavacini, LA Chou, TC Ruprecht, RM
Citation: R. Hofmann-lehmann et al., Passive immunization against oral AIDS virus transmission: An approach to prevent mother-to-infant HIV-1 transmission?, J MED PRIM, 30(4), 2001, pp. 190-196
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge
Authors: Hofmann-Lehmann, R Vlasak, J Rasmussen, RA Smith, BA Baba, TW Liska, V Ferrantelli, F Montefiori, DC McClure, HM Anderson, DC Bernacky, BJ Rizvi, TA Schmidt, R Hill, LR Keeling, ME Katinger, H Stiegler, G Cavacini, LA Posner, MR Chou, TC Andersen, J Ruprecht, RM
Citation: R. Hofmann-lehmann et al., Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge, J VIROLOGY, 75(16), 2001, pp. 7470-7480
A Phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck
Authors: Colevas, AD Amrein, PC Gomolin, H Barton, JJ Read, RR Adak, S Benner, S Costello, R Posner, MR
Citation: Ad. Colevas et al., A Phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck, CANCER, 92(2), 2001, pp. 326-331
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
Authors: Baba, TW Liska, V Hofmann-Lehmann, R Vlasak, J Xu, WD Ayehunie, S Cavacini, LA Posner, MR Katinger, H Stiegler, G Bernacky, BJ Rizvi, TA Schmidt, R Hill, LR Keeling, ME Lu, YC Wright, JE Chou, TC Ruprecht, RM
Citation: Tw. Baba et al., Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, NAT MED, 6(2), 2000, pp. 200-206
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
Authors: Colevas, AD Adak, S Amrein, PC Barton, JJ Costello, R Posner, MR
Citation: Ad. Colevas et al., A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck, ANN ONCOL, 11(5), 2000, pp. 535-539
The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck
Authors: Posner, MR Colevas, AD Tishler, RB
Citation: Mr. Posner et al., The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck, SEMIN ONCOL, 27(4), 2000, pp. 13-24
Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2
Authors: Cataltepe, S Schick, C Luke, CJ Pak, SCO Goldfarb, D Chen, P Tanasiyevic, MJ Posner, MR Silverman, GA
Citation: S. Cataltepe et al., Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2, CLIN CHIM A, 295(1-2), 2000, pp. 107-127
A human anti-HIV autoantibody enhances EBV transformation and HIV infection
Authors: Cavacini, LA Wisnewski, A Peterson, JE Montefiori, D Emes, C Duval, M Kingsbury, G Wang, A Scadden, D Posner, MR
Citation: La. Cavacini et al., A human anti-HIV autoantibody enhances EBV transformation and HIV infection, CLIN IMMUNO, 93(3), 1999, pp. 263-273
Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines
Authors: Posner, MR Cavacini, LA Upton, MP Tillman, KC Gornstein, ER Norris, CM
Citation: Mr. Posner et al., Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines, CLIN CANC R, 5(8), 1999, pp. 2261-2270
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
Authors: Colevas, AD Norris, CM Tishler, RB Fried, MP Gomolin, HI Amrein, P Nixon, A Lamb, C Costello, R Barton, J Read, R Adak, S Posner, MR
Citation: Ad. Colevas et al., Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck, J CL ONCOL, 17(11), 1999, pp. 3503-3511
An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies
Authors: Tishler, RB Busse, PM Norris, CM Rossi, R Poulin, M Thornhill, L Costello, R Peters, ES Colevas, AD Posner, MR
Citation: Rb. Tishler et al., An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies, INT J RAD O, 43(5), 1999, pp. 1001-1008
Minimal incidence of serum antibodies reactive with intact primary isolatevirions in human immunodeficiency virus type 1-infected individuals
Authors: Cavacini, LA Peterson, JE Nappi, E Duval, M Goldstein, R Mayer, K Posner, MR
Citation: La. Cavacini et al., Minimal incidence of serum antibodies reactive with intact primary isolatevirions in human immunodeficiency virus type 1-infected individuals, J VIROLOGY, 73(11), 1999, pp. 9638-9641
Risultati: 1-16 |